Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study (original) (raw)

Comparison of TSH Levels with Liquid Formulation Versus Tablet Formulations of Levothyroxine in the Treatment of Adult Hypothyroidism

Alessandro Scorsone, Lidia Ferrara, Gabriella Saura

Endocrine Practice, 2014

View PDFchevron_right

Treatment pattern and frequency of serum TSH measurement in users of different levothyroxine formulations: a population-based study during the years 2009–2015

Vincenzo Arcoraci

Endocrine, 2017

View PDFchevron_right

Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis

Marco Centanni

Frontiers in endocrinology, 2018

View PDFchevron_right

Weekly Versus Daily Levothyroxine Tablet Replacement in Adults with Hypothyroidism: A Meta-Analyis

Cecilia Jimeno

Journal of the ASEAN Federation of Endocrine Societies, 2021

View PDFchevron_right

Therapeutic Equivalence of a New Preparation of Liquid Levothyroxine with Tablets in Patients with Overt Primary Hypothyroidism

Marina Michalaki

European Thyroid Journal, 2020

View PDFchevron_right

Evaluation of the common mistakes made by patients in the use of Levothyroxine

Yasin Şimşek

European Journal of Internal Medicine, 2014

View PDFchevron_right

A bioequivalence study of Levothyroxine tablets versus an oral Levothyroxine solution in healthy volunteers

Anastasia Pouli

European Journal of Drug Metabolism and Pharmacokinetics, 2006

View PDFchevron_right

The Economic Impact of Changing Levothyroxine Formulations in Difficult-to-Treat Hypothyroid Patients: An Evidence-Based Model

Walter Sandulli

Pharmacoeconomics: Open Access, 2017

View PDFchevron_right

Misuse of levothyroxine and the rate of achieving target thyroid-stimulating hormone in levothyroxine treatment

Fatma Yaylaci Karahalil

Biomedical Research-tokyo, 2017

View PDFchevron_right

Liquid and softgel levothyroxine use in clinical practice: state of the art

Marco Centanni

Endocrine, 2016

View PDFchevron_right

Treatment of refractory and severe hypothyroidism with sublingual levothyroxine in liquid formulation

Bernadette Biondi

Endocrine, 2017

View PDFchevron_right

Effects of restricting levothyroxine dosage strength availability

Kenneth Ain

Pharmacotherapy

View PDFchevron_right

Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project

Walter Sandulli

Drugs in R&D, 2015

View PDFchevron_right

Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review

Sanaa Mrabeti

Endocrine Connections

View PDFchevron_right

Shift From Levothyroxine Tablets To Liquid Formulation At Breakfast Improves Quality Of Life Of Hypothyroid Patients

Franco Grimaldi

Endocrine, metabolic & immune disorders drug targets, 2018

View PDFchevron_right

The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine

Gabriella Cavallini

Frontiers in Endocrinology, 2021

View PDFchevron_right

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report

Marco Centanni

Journal of Endocrinological Investigation

View PDFchevron_right

A Report of the Mayo Clinic Experience on the Levothyroxine Absorption Test

Bernadette Biondi

Clinical Thyroidology, 2020

View PDFchevron_right

Individualised requirements for optimum treatment of hypothyroidism: complex needs, limited options

John E M Midgley, Rudolf Hoermann, Johannes W Dietrich

Drugs in Context, 2019

View PDFchevron_right

Drug interactions in users of tablet vs. oral liquid levothyroxine formulations: a real-world evidence study in primary care

Iacopo Cricelli

Endocrine, 2017

View PDFchevron_right

Authors’ Reply to Yu et al.: “Levothyrox® New and Old Formulations: Are They Switchable for Millions of Patients?”

Pierre-louis Toutain

Clinical Pharmacokinetics, 2019

View PDFchevron_right

Bioequivalence of two levothyroxine tablet formulations without and with mathematical adjustment for basal thyroxine levels in healthy Argentinian volunteers: A single-dose, randomized, open-label, crossover study

Antonio De Los Santos

Clinical Therapeutics, 2008

View PDFchevron_right

Levothyrox® New and Old Formulations: Are they Switchable for Millions of Patients?

Didier Concordet

Clinical Pharmacokinetics

View PDFchevron_right

A Study Protocol on Daily Verses Weekly LevothyroxineTherapy in Hypothyroid Subjects

soumyabrata roy chaudhuri

2020

View PDFchevron_right

Guidelines for the Treatment of Hypothyroidism Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement

Aj Ghosh

View PDFchevron_right

Treatment of Hypothyroidism by the American Thyroid Association Task Force on Thyroid Hormone Replacement

Lina Caicedo

View PDFchevron_right

Treating primary hypothyroidism with weekly doses of levothyroxine: a randomized, single-blind, crossover study

Gilberto Paz-filho

Arquivos Brasileiros de Endocrinologia & Metabologia, 2012

View PDFchevron_right